Would sinus venosus ASD repair reduce risk of recurrent CVAs for a 60 years old female with sickle cell disease? If so how much significant?
How much sinus venosus ASD plays a role this scenario in addition to vaso-occlusive crisis?
Other than recurrent CVAs the patient does not meet any other criteria for ASD repair.